3.30–4.30pm 22 September 2017
Emeritus Professor Angela Dulhunty, Dulhunty Group - Muscle Research, The Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 22 September 2017
Professor David Vaux, Deputy Director and Joint Division Head, Cell Signalling and Cell Death, WEHI
Science is knowledge gained through repeated observation or experiment. It is communicated through publication of papers in...
12.30–1.30pm 21 September 2017
Dr Doris Beylkin, GE Dharmacon, Colorado, USA
RNAi has long been used for functional genomics screening in cell-based assays. CRISPR is newer to this application, but showing promise as a complimentary, and possibly more...
3.30–4.30pm 15 September 2017
Dr Saba Gharaei, The Stuart Group - Neuronal Signalling, JCSMR
3.30–4.30pm 14 September 2017
Konstantin Panov, PhD, Queen`s University, Belfast
12–1pm 13 September 2017
Making sense of a novel RC3H1 nonsense mutation associated with Hemopagocytic Lymphohistocytosis (HLH)
Dr Vicki Athanasopoulos, The Vinuesa Group, JCSMR
The Aryl Hydrocarbon Receptor (AhR)-dependant cytotoxic...
3.30–4.30pm 8 September 2017
Emeritus Professor Trevor Lamb, The Lamb Group - Visual Neuroscience, The Eccles Institute for Neurocience, JCSMR, ANU
3.30–4.30pm 8 September 2017
Barbara Holland, University of Tasmania
Joint work with: Jeremy Sumner, David Liberles, Michael Woodhams, Michael Charleston
These days the most widely used methods of phylogenetic inference are based...
12–1pm 6 September 2017
Mr Hao Yang, The McMorran Group JCSMR.
Final PhD Seminar -
12–1pm 1 September 2017
CANCELLED DUE TO FLIGHT DELAYS - WILL BE RESCHEDULED
Professor Trevor Kilpatrick, Director, Melbourne Neuroscience Institute, University of Melbourne, Melbourne, VIC
Multiple sclerosis (MS) is traditionally considered a T...
3.30–4.30pm 31 August 2017
Dr Denis Bauer, CSIRO
The genome holds information on prospective disease risk. Hence by 2025, 50% of the world population will have their genome sequenced. This will create more data than Astronomy, Twitter, and YouTube...
5.30–6.15pm 28 August 2017
The World Health Organization estimated that the number of people with diabetes globally was 442 million in 2014. In Australia, it is the most common cause of renal failure, of blindness in working age adults, and of non-...
12–1pm 25 August 2017
Please note - this seminar has been been cancelled due to illness and will be rescheduled.
Brandon Wainwright is Professor and Director of the Institute for Molecular Bioscience (IMB) at the University of Queensland. The...
12–1pm 18 August 2017
Professor Jane Visvader, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC
Breast tumours exhibit enormous heterogeneity at the histological and molecular levels and furthermore can manifest differently...
10.30–11.30am 16 August 2017
As medical researchers develop new assays that can lead to the emergence of breakthrough medicines, they must be able to swiftly access and use the compounds needed for development. Compounds Australia, located at...
3.30–4.30pm 11 August 2017
Dr Sarah Hulme, The Billups Group, The Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 11 August 2017
Professor Sean Grimmond, Director & The Bertalli Chair in Cancer Medicine, University of Melbourne Centre for Cancer Research, Melbourne, VIC
It is now well established that a cancer’s mutational burden drives tumour...
4.30–6.30pm 10 August 2017
Are you interested in studying at The John Curtin School of Medical Research in 2018?
Are you currently considering enrolling in an Honours, Masters or PhD program?
Become part of one of our research teams in Cancer,...
12–1pm 9 August 2017
Associate Professor Anselm Enders, The Enders Group, JCSMR
Novel mouse models for human primary immunodeficiencies
Dr Katrina Randall, ACT Health and JCSMR
Affinity maturation in Primurus VavBcl2 transgenic...
3.30–4.30pm 4 August 2017
Professor Veronica Egger, University of Regensburg, Regensburg, Germany
The vertebrate olfactory bulb processes olfactory stimuli within a two-stage network, the first located within the glomerular input layer and the second...